NCT05936242 Evaluation of Main Determinants of Postprandial Glucose Response in Type 1 Diabetes
| NCT ID | NCT05936242 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Federico II University |
| Condition | Type 1 Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2021-05-18 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2021-05-18 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to explore inter- and intra-individual determinants of postprandial glucose response in patients with type 1 diabetes using continous glucose monitoring (CGM). Blood samples and anthropometrics will be collected during hospital visit. Participants will be asked to: * record a seven-day food diary * complete EPIC food frequency questionnaire * complete questionnaires on sleep hygiene * collect a stool sample
Eligibility Criteria
Inclusion Criteria: * Type 1 Diabetes Exclusion Criteria: * Pregnancy and/or breastfeeding * Other chronic or acute diseases * Use of antibiotics in the past 3 months
Frequently Asked Questions
Who can join the NCT05936242 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05936242 currently recruiting?
Yes, NCT05936242 is actively recruiting participants. Visit ClinicalTrials.gov or contact Federico II University to inquire about joining.
Where is the NCT05936242 trial being conducted?
This trial is being conducted at Naples, Italy.
Who is sponsoring the NCT05936242 clinical trial?
NCT05936242 is sponsored by Federico II University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.